application): This PPG has one administrative core element and three scientific core elements (the mass spectrometry unit, the human liver bank unit, and the computational core unit) that have been established to provide shared resources critical to the day-to-day needs of the participating investigators and to the future scientific development of the PPG as a whole. Dr. Trager will direct all components of this core unit and manage the administrative components with support for a budget coordinator. In managing the scientific components, Dr. Trager will be assisted by Dr. Howald, the Technical Director of the Mass Spectrometry Center, Dr. Thummel, the Director of the Human Liver and Intestine Bank (with the aid of an assistant). Dr. Perkins, the Director of the Division of Transplantation in the Department of Surgery (to facilitate the acquisition of samples for the human tissue bank), Dr. Jones, the Director of the Computational Component of the Core Unit, and Dr. Hackett of the Division of Transplantation in the Department of Medicinal Chemistry (who will provide expertise and support in protein biochemistry, protein mass spectrometry, and micro-capillary chromatography). Dr. Kharasch will provide clinical expertise and collaborate on the in vivo studies described in Projects 1 and 4. The mass spectrometry center contains six instruments with different capabilities. These instruments will be used for drug and metabolite determinations, protein mass determinations, and peptide sequencing. This center will be used extensively by all four projects associated with this PPG proposal. The human tissue bank now contains well-characterized frozen samples of 53 human livers and 60 human intestines. These tissues are available to all investigators affiliated with the PPG. The procurement of human livers and intestines will continue throughout the proposed funding period to replace tissue that will be utilized in the four research projects. The computational component of this core will be provided as part of a consortium agreement with the University of Rochester in New York, where Dr. Jones is located along with one full-time and one part-time assistant. Three dimensional active site models are currently being developed as part of the research efforts in Projects 2 and 4, and there is some expectation that other projects in the PPG may eventually draw on this resource. Funds are also requested to buy two major pieces of equipment: an Innova 90-6 argon laser that would be used in photoaffinity labeling experiments in Projects 2 and 4, and a Cary 4 Bio UV-Vis spectrophotometer to be used in the four research projects in this PPG proposal.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM032165-20
Application #
6643655
Study Section
Project Start
2002-08-01
Project End
2003-07-31
Budget Start
Budget End
Support Year
20
Fiscal Year
2002
Total Cost
$254,104
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Wong, Timothy; Wang, Zhican; Chapron, Brian D et al. (2018) Polymorphic Human Sulfotransferase 2A1 Mediates the Formation of 25-Hydroxyvitamin D3-3-O-Sulfate, a Major Circulating Vitamin D Metabolite in Humans. Drug Metab Dispos 46:367-379
Shirasaka, Y; Chaudhry, A S; McDonald, M et al. (2016) Interindividual variability of CYP2C19-catalyzed drug metabolism due to differences in gene diplotypes and cytochrome P450 oxidoreductase content. Pharmacogenomics J 16:375-87
Manoj, Kelath Murali; Parashar, Abhinav; Gade, Sudeep K et al. (2016) Functioning of Microsomal Cytochrome P450s: Murburn Concept Explains the Metabolism of Xenobiotics in Hepatocytes. Front Pharmacol 7:161
Stamper, Brendan D; Garcia, Michael L; Nguyen, Duy Q et al. (2015) p53 Contributes to Differentiating Gene Expression Following Exposure to Acetaminophen and Its Less Hepatotoxic Regioisomer Both In Vitro and In Vivo. Gene Regul Syst Bio 9:1-14
McDonald, Matthew G; Au, Nicholas T; Rettie, Allan E (2015) P450-Based Drug-Drug Interactions of Amiodarone and its Metabolites: Diversity of Inhibitory Mechanisms. Drug Metab Dispos 43:1661-9
Chaudhry, Amarjit S; Prasad, Bhagwat; Shirasaka, Yoshiyuki et al. (2015) The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles. Drug Metab Dispos 43:1226-35
Liu, Li; Collier, Ann C; Link, Jeanne M et al. (2015) Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study. Drug Metab Dispos 43:1795-804
Ho, Han Kiat; Chan, James Chun Yip; Hardy, Klarissa D et al. (2015) Mechanism-based inactivation of CYP450 enzymes: a case study of lapatinib. Drug Metab Rev 47:21-8
Chapron, Brian; Risler, Linda; Phillips, Brian et al. (2015) Reversible, time-dependent inhibition of CYP3A-mediated metabolism of midazolam and tacrolimus by telaprevir in human liver microsomes. J Pharm Pharm Sci 18:101-11
Sager, J E; Lutz, J D; Foti, R S et al. (2014) Fluoxetine- and norfluoxetine-mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19, and CYP3A4. Clin Pharmacol Ther 95:653-62

Showing the most recent 10 out of 361 publications